Literature DB >> 8453185

Musculoskeletal disease in the aged. Diagnosis and management.

R F Afable1, W H Ettinger.   

Abstract

Musculoskeletal diseases are the most prevalent conditions affecting the elderly today and cause significant suffering and disability in this population. The diagnosis of musculoskeletal disorders in older persons requires knowledge of the diseases which affect this age group, familiarity with the signs and symptoms, and a working knowledge of laboratory and radiographic abnormalities. Treatment of these disorders is based upon the principles of pain relief and maintenance of function. A multifaceted approach includes physical therapy, patient education, psychological support and the use of medications. Simple analgesics like paracetamol (acetaminophen) are gaining increased importance in the treatment of symptomatic disease. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most utilised pharmacological treatment and are effective in relieving pain and improving function in most patients. However, elderly persons are at increased risk for NSAID-induced toxicity, and drug choices should be made with this in mind. New data are becoming available as to the relative toxicity of the different NSAIDs, and this should help in choosing between these medications. Disease-modifying drug therapy is the most difficult to administer in elderly subjects. Potential toxicity must be weighed against realistic benefit in older persons prior to and during remittive therapy. With appropriate precautions, these agents can prove invaluable in the treatment of older persons with serious musculoskeletal disease.

Entities:  

Mesh:

Year:  1993        PMID: 8453185     DOI: 10.2165/00002512-199303010-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  44 in total

Review 1.  Exercise and arthritis.

Authors:  L H Gerber
Journal:  Bull Rheum Dis       Date:  1990

2.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

Authors:  J D Bradley; K D Brandt; B P Katz; L A Kalasinski; S I Ryan
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

3.  Osteo-arthrosis. Prevalence in the population and relationship between symptoms and x-ray changes.

Authors:  J S Lawrence; J M Bremner; F Bier
Journal:  Ann Rheum Dis       Date:  1966-01       Impact factor: 19.103

Review 4.  Fibromyalgia. 1. Review of a common rheumatologic syndrome.

Authors:  P K Hench; M M Mitler
Journal:  Postgrad Med       Date:  1986-11-15       Impact factor: 3.840

5.  High-intensity strength training in nonagenarians. Effects on skeletal muscle.

Authors:  M A Fiatarone; E C Marks; N D Ryan; C N Meredith; L A Lipsitz; W J Evans
Journal:  JAMA       Date:  1990-06-13       Impact factor: 56.272

6.  The effect of age on methotrexate efficacy and toxicity.

Authors:  F Wolfe; M A Cathey
Journal:  J Rheumatol       Date:  1991-07       Impact factor: 4.666

7.  The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study.

Authors:  D T Felson; A Naimark; J Anderson; L Kazis; W Castelli; R F Meenan
Journal:  Arthritis Rheum       Date:  1987-08

Review 8.  Approach to the diagnosis and management of musculoskeletal disease.

Authors:  W H Ettinger
Journal:  Clin Geriatr Med       Date:  1988-05       Impact factor: 3.076

9.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

Authors:  M R Griffin; J M Piper; J R Daugherty; M Snowden; W A Ray
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

10.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

Authors:  M C Allison; A G Howatson; C J Torrance; F D Lee; R I Russell
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

View more
  1 in total

1.  Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics.

Authors:  A E Eggen; M Andrew
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.